News

Ozempic (semaglutide) is a once-weekly injectable medication for treating type 2 diabetes and chronic kidney disease and lowering cardiovascular risks. It typically takes at least 4 weeks to start ...
As medical professionals and researchers continue searching for effective treatments, a drug called Ozempic (semaglutide) has emerged as a potential therapy. Originally approved for type 2 ...